Chemplast Sanmar Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹3,189 Cr
- ROE
- -6.80%
- Price to sales
- 0.74
- Debt to equity
- 1.11
- 52W high / low
- ₹408 / ₹165
- Sales growth (5Y)
- 2.14%
- EBITDA margin
- 1.56%
- Net profit margin
- -3.08%
- Promoter holding
- 54.99%
- Sales (last year)
- ₹4,249 Cr
It is a major manufacturer of Speciality Chemicals such as Specialty Paste PVC resin and Custom Manufactured Chemicals for agro-chemical, pharmaceutical and fine chemicals sector. The company also produces other chemicals such as Caustic Soda, Chlorochemicals, Hydrogen Peroxide, Refrigerant gas and Industrial Salt. The manufacturing facilities are located at Mettur, Berigai and Vedaranyam in Tamil Nadu and Karaikal in the Union Territory of Puducherry.
Guidance scorecard · Q1 FY27 call
What Chemplast Sanmar Ltd's management guided
and where it ranks in Chemicals & Petrochemicals
Chemicals & Petrochemicals
RevenueQ1 FY27 call
10–20%- Specialty Chemicals segment shows strong growth with 21% YoY volume increase in Q1 FY27; expected to continue ramping up with 14 commercial molecules and ~50 in development across agchem, pharma, and specialty sectors.
- Custom Manufacturing (CMCD) business has a strong order book and is on track to achieve INR1,000 crores revenue target; ramp-up of new capacities progressing with full utilization expected by FY27 end.
- Suspension PVC segment facing short-term challenges but expected to improve from Q3 FY27 onwards due to better PVC/VCM spreads supported by protective duties and market recovery.
2 more points from Chemplast Sanmar Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what Chemplast Sanmar Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Chemplast Sanmar is investing in capacity expansion in the specialty chemicals segment to drive profitable growth.
- The Custom Manufacturing Chemicals Division (CMCD) capacity has expanded significantly, for example from roughly 1,100 tons to 5,400 tons.
- Resources have been invested in Europe and Japan to support business development and possibly diversify beyond agrochemicals into pharmaceuticals and specialty chemicals.
- The company is on track to commission 14,000 tons of refrigerant gas (R32) capacity by the end of the current fiscal year.
- Capex for growth is ongoing, with negative free cash flows due to investments, but liquidity and cash conservation help manage debt servicing.
2 more points from Chemplast Sanmar Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
See what Chemplast Sanmar Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
Rising- Custom Manufacturing business has a good order book with strong outlook and performance in Q1.
- The CMCD (Custom Manufacturing & Development) segment has a healthy order book supporting 60-70% utilization of commissioned assets.
- Currently, 14 molecules are in commercial production with around 50 molecules in various development stages in the pipeline.
- Strong order backlog exists for the remaining 9 months of the year.
- The business anticipates continued ramp-up and commercialization of additional molecules in the coming quarters.
- Active efforts are underway to diversify beyond agchem to pharma and specialty chemicals with projects in progress.
2 more points from Chemplast Sanmar Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹263 Cr | 3.4 | |
| 2 | 40%+ | Flat | ₹4,375 Cr | 83.7 | |
| 3 | 40%+ | Flat | ₹3,259 Cr | 4.0 | |
| 4 | 40%+ | Flat | ₹145 Cr | 15.9 | |
| 5 | 20–40% | Up 2%+ | ₹1.81L Cr | 90.9 | |
| 6 | 20–40% | Up 2%+ | ₹48,366 Cr | 78.3 |
Sign up free to see every company in the sector ranking and track Chemplast Sanmar Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Chemplast Sanmar Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Chemplast Sanmar Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,147 | 996 | 988 | 888 | 1,051 | 1,145 | 993 | 1,058 | 1,151 | 1,100 | 1,033 | 835 | 1,256 |
| Expenses + | 1,049 | 1,031 | 942 | 895 | 1,030 | 1,021 | 967 | 1,026 | 1,114 | 1,083 | 990 | 892 | 1,061 |
| Operating Profit | 97 | -35 | 46 | -7 | 21 | 124 | 26 | 32 | 37 | 17 | 43 | -57 | 194 |
| OPM % | 8% | -3% | 5% | -1% | 2% | 11% | 3% | 3% | 3% | 2% | 4% | -7% | 15% |
| Other Income + | 31 | 18 | 37 | 13 | 13 | 12 | 11 | 11 | 14 | 9 | 7 | 5 | -143 |
| Interest | 38 | 44 | 39 | 47 | 51 | 59 | 57 | 59 | 62 | 59 | 60 | 58 | 58 |
| Depreciation | 33 | 32 | 35 | 38 | 46 | 45 | 45 | 47 | 62 | 53 | 52 | 53 | 55 |
| Profit before tax | 56 | -93 | 9 | -78 | -63 | 32 | -65 | -63 | -73 | -86 | -62 | -163 | -61 |
| Tax % | 18% | -31% | -182% | 14% | -51% | 26% | -52% | -22% | -26% | -26% | -18% | -27% | -26% |
| Net Profit + | 46 | -64 | 26 | -89 | -31 | 24 | -31 | -49 | -54 | -64 | -51 | -119 | -45 |
| EPS in Rs | 2.91 | -4.05 | 1.65 | -5.65 | -1.97 | 1.51 | -1.98 | -3.09 | -3.43 | -4.06 | -3.23 | -7.54 | -2.87 |
Financials of Chemplast Sanmar Ltd
Profit & Loss
Annual income statement trend
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 1,254 | 1,258 | 3,799 | 5,892 | 4,941 | 3,923 | 4,346 | 4,224 |
| Expenses + | 969 | 1,011 | 3,171 | 4,695 | 4,473 | 3,902 | 4,127 | 4,026 |
| Operating Profit | 286 | 247 | 628 | 1,197 | 468 | 21 | 219 | 198 |
| OPM % | 23% | 20% | 17% | 20% | 9% | 1% | 5% | 5% |
| Other Income + | 12 | 8 | 484 | 57 | -1 | 85 | 47 | -122 |
| Interest | 48 | 95 | 433 | 322 | 154 | 181 | 236 | 235 |
| Depreciation | 56 | 87 | 131 | 137 | 142 | 151 | 199 | 213 |
| Profit before tax | 193 | 72 | 547 | 796 | 172 | -226 | -169 | -372 |
| Tax % | 39% | 36% | 25% | 18% | 11% | -30% | -35% | -25% |
| Net Profit + | 118 | 46 | 410 | 649 | 152 | -158 | -110 | -280 |
| EPS in Rs | 14.81 | 6.88 | 30.59 | 41.03 | 9.64 | -10.02 | -6.98 | -17.70 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Chemplast Sanmar Ltd
Balance Sheet
Capital structure and asset base
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 79 | 79 | 79 | 79 | 79 |
| Reserves | 2,433 | 1,845 | -417 | 1,626 | 1,779 | 1,622 | 1,989 | 1,676 |
| Borrowings + | 253 | 1,289 | 2,127 | 882 | 1,019 | 1,548 | 1,842 | 1,952 |
| Other Liabilities + | 1,049 | 906 | 2,709 | 3,015 | 2,959 | 2,782 | 2,593 | 2,609 |
| Total Liabilities | 3,802 | 4,108 | 4,487 | 5,602 | 5,837 | 6,030 | 6,503 | 6,315 |
| Fixed Assets + | 2,108 | 2,174 | 3,148 | 3,259 | 3,186 | 3,907 | 4,499 | 4,386 |
| CWIP | 117 | 8 | 25 | 34 | 402 | 190 | 137 | 341 |
| Investments | 1,159 | 1,458 | 0 | 0 | 0 | 0 | 0 | 95 |
| Other Assets + | 418 | 467 | 1,313 | 2,309 | 2,249 | 1,934 | 1,866 | 1,493 |
| Total Assets | 3,802 | 4,108 | 4,487 | 5,602 | 5,837 | 6,030 | 6,503 | 6,315 |
Financials of Chemplast Sanmar Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 166 | 1,076 | 901 | 355 | -245 | 172 | 294 | |
| Cash from Investing Activity + | -438 | 2,152 | 108 | -217 | -524 | -407 | -232 | |
| Cash from Financing Activity + | 298 | -3,017 | -313 | -27 | 382 | 66 | -187 | |
| Net Cash Flow | 26 | 211 | 696 | 111 | -387 | -170 | -124 | |
| Free Cash Flow | 116 | 1,022 | 849 | -64 | -833 | -188 | -22 | |
| CFO/OP | 83% | 181% | 90% | 96% | -1,049% | 67% | 149% |
Financials of Chemplast Sanmar Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19 | 14 | 7 | 12 | 11 | 18 | 13 | 8 |
| Inventory Days | 183 | 158 | 70 | 70 | 73 | 77 | 87 | 82 |
| Days Payable | 200 | 187 | 285 | 189 | 212 | 235 | 221 | 224 |
| Cash Conversion Cycle | 2 | -16 | -208 | -108 | -128 | -141 | -121 | -133 |
| Working Capital Days | -45 | -5 | -124 | -76 | -95 | -134 | -140 | -172 |
| ROCE % | 6% | 21% | 50% | 15% | -2% | 2% | 0% |
Guidance history
How Chemplast Sanmar Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Flat | Planned | — | Rising |
| Q4 FY26 call → | 10–20% | Flat | Planned | — | — |
| Q3 FY26 call → | 10–20% | Flat | Planned | — | — |
| Q2 FY26 call → | 10–20% | Flat | Planned | Planned | Rising |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
14 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −49.6% | 5% |
| Last 6 months | −11.9% | 34% |
| Last 3 months | −0.2% | 63% |
The price is 74.9% below its all-time high of ₹801.3 (8 Oct 2021). Stocks more than 20% below their peak have their score halved, so 28 became 14.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Chemplast Sanmar Ltd: 0.4 × 5 + 0.4 × 34 + 0.2 × 63 = 28, halved to 14 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Chemplast Sanmar Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
- Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
- NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.